Please login to the form below

Not currently logged in
Email:
Password:

women's health

This page shows the latest women's health news and features for those working in and with pharma, biotech and healthcare.

'Femtech' poised to explode, with applications set to trigger healthcare disruption

'Femtech' poised to explode, with applications set to trigger healthcare disruption

Will be driven by strong funding and positive regulatory environment. The market for digital applications for women’s health and wellbeing is set for ‘explosive growth’, driven by almost $1 billion ... Such femtech applications target reproductive,

Latest news

  • MHRA suspends new prescriptions of fibroid drug Esmya MHRA suspends new prescriptions of fibroid drug Esmya

    In December, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the treatment for abnormal bleeding in women with uterine fibroids after four cases of serious liver injury - ... Allergan has said that it sees Esmya as a

  • Ferring agrees Chinese reproductive medicine research deal Ferring agrees Chinese reproductive medicine research deal

    This collaboration forms the next phase in our ongoing effects to advance knowledge and care in reproductive medicine and women’s health.”. ... Building Tomorrow initiative, which aims to improve reproductive health both in China and worldwide.

  • Teva cuts 25% of workforce, with Israel taking a heavy toll Teva cuts 25% of workforce, with Israel taking a heavy toll

    Israel’s biggest trade union Histadrut has already threatened strike action to protest the cutbacks. ... The company has already made some changes to its organisational structure, for example selling off its women’s health business for $2.5bn,

  • Teva sheds R&D chief after new CEO takes the helm Teva sheds R&D chief after new CEO takes the helm

    CEOs have struggled to accomplish due to political backlash that has sometimes found support within the company’s own board. ... laquinimod. In September, shortly after the new CEO was announced, Teva kicked off its restructuring drive with two

  • Teva offloads women's health unit in quickfire deals Teva offloads women's health unit in quickfire deals

    Teva offloads women's health unit in quickfire deals. The Israeli pharma group is also set to sell its oncology and pain business. ... Teva has announced two deals in quick succession to sell off the entirety of its women's health business assets,

More from news
Approximately 5 fully matching, plus 80 partially matching documents found.

Latest Intelligence

  • Pharma deals continue to slide Pharma deals continue to slide

    Novartis has announced a price of $475, 000 per treatment following discussion with health assessment authorities. ... The business has not performed because of generic price pressures so Teva has reduced its dividend, is laying off 7, 000 staff and is

  • Deal Watch March 2017 Deal Watch March 2017

    Duchesnay, the Canadian women’s health company, has acquired from Shionogi the rights to market Osphena, another oral treatment for dyspareunia, in North America. ... And that’s the news from the Deal Watch team, where the women are strong, the men

  • Deal Watch February 2017 Deal Watch February 2017

    women's health. ... Licence with co-promotion option. 2, 057. Cynosure/ Hologic. Medical aesthetics portfolio inc non-invasive body contouring, hair removal, skin revitalisation and women's health.

  • Having it all: Women in wealthy countries consider what makes them happy Having it all: Women in wealthy countries consider what makes them happy

    A survey conducted by The Economist Intelligence Unit (EIU) on behalf of Merck Consumer Health, and presented in the recently released study Women's health and well-being: evolving definitions and ... Indeed, the main factor in promoting well-being is

  • Women's Health and Well-Being Women's Health and Well-Being

    The basis for this debate was an Economist Intelligence Unit’ s (EIU) report commissioned by Merck Consumer Health on Women’ s Health and Well-Being: Evolving Definitions and Practices. ... Read more about the Global Consumer Health Debate and the

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

  • Topas Therapeutics appoints chief development officer and chief medical officer Topas Therapeutics appoints chief development officer and chief medical officer

    Topas Therapeutics has appointed Rupert Sandbrink as its new chief development officer and chief medical officer, a role that will see him lead the German group’s development and regulatory affairs. ... Prior to that, he held several roles at Bayer,

  • Anish Mehta appointed CEO of new women's health business Anish Mehta appointed CEO of new women's health business

    Anish Mehta appointed CEO of new women's health business. Will head up the former Teva portoflio CVC Capital Partners recently acquired. ... The combination of high quality products and a talented team creates a unique opportunity for us to build a

  • Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

    He was also chairman of GSK’s global R&D organisation for eight years and led the global integration of Novartis’vaccine unit into GSK. ... Additionally, Dr Frank Verwiel (pictured left). joins the group’s board of directors after serving ObsEva SA,

  • Clark Health Communications expands team Clark Health Communications expands team

    responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business. ... Campbell will support and assist the team across its women’s health, gastroenterology and haemophilia accounts.

  • Sam Agus takes up new role at Hansa Medical Sam Agus takes up new role at Hansa Medical

    Sam Agus takes up new role at Hansa Medical. Will focus on the firm’s lead kidney transplantation project IdeS. ... With experience in medical strategy, multidisciplinary team leadership, medical marketing and clinical trial design, Agus’s therapy

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

  • Double hire for Clark Health Communications (CHC)

    Claire will be working on CHC’ s depression and women’ s health business. ... C ontact:. Hannah Clarke. Clark Health Communications. T: 44 (0) 207 492 1900.

  • A better future, or too ambitious to be true?

    A better future, or too ambitious to be true? Simon Goldsborough, Account Director, discusses the $25bn pledged by the UN to improve women’ s, children’ s and adolescents’ health. ... According to Dr Flavia Bustreo, Assistant Director-General,

  • Women's health in emerging markets

    Women's health in emerging markets. Why can understanding and improving women’ s health in emerging markets be challenging? ... Associate Director Rachel Howard and Research Manager Helen Mace discuss why market research is useful for understanding

  • Beyond Andrology: Trends in Men’s Health in Emerging Markets

    Beyond Andrology: Trends in Men’ s Health in Emerging Markets. Published in eyeforpharma July 2016 by Rachel Howard. ... Men’ s health in emerging markets is more likely to be brought about by tackling attitudes than by improving access.In my last

  • The Opportunity for Womens Health in Emerging Markets

    The Opportunity for Women’ s Health in Emerging Markets. Published in eyeforpharma April 2016 by Rachel Howard. ... In our latest article for eyeforpharma, Associate Director Rachel Howard looks at what we mean by "women's health" and outlines some of

More from PMHub
Approximately 3 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics